U.S. FDA Mulls EFPIA Proposal on Enhanced Inspections
This article was originally published in PharmAsia News
Executive Summary
The European pharmaceutical industry has caught the U.S. FDA’s attention with a sweeping proposal for eventually putting the world’s inspectorates on the same page and simplifying regulatory compliance challenges for global manufacturers.